{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:48Z","timestamp":1786997928994,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.urolonc.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T16:15:49Z","timestamp":1341332149000},"page":"1806-1811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Plasma thymosin-\u03b11 level as a potential biomarker in urothelial and renal cell carcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Yeong-Chin","family":"Jou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Shyan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Yen","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syue-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Tzu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Tair","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Li","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Shin","family":"Tzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2012.03.011_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2010.12.042","article-title":"European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update","volume":"59","author":"Roupr\u00eat","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.03.011_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eururo.2004.04.011","article-title":"EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma","volume":"46","author":"Oosterlinck","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.03.011_bib3","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2012.03.011_bib4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","article-title":"Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract","volume":"104","author":"Colin","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2012.03.011_bib5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.0.CO;2-B","article-title":"Unusual clinical presentation of upper urothelial carcinoma in Taiwan","volume":"85","author":"Chou","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2012.03.011_bib6","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/S0022-5347(05)64991-9","article-title":"Renal cell carcinoma invading the urinary collecting system: Implications for staging","volume":"167","author":"Uzzo","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.03.011_bib7","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/cncr.10609","article-title":"Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma","volume":"94","author":"Yoshimura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2012.03.011_bib8","first-page":"92","article-title":"Surfing on prothymosin \u03b1 proliferation and anti-apoptotic properties","volume":"53","author":"Letsas","year":"2006","journal-title":"Neoplasma"},{"key":"10.1016\/j.urolonc.2012.03.011_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.urology.2008.05.031","article-title":"Aberrant prothymosin-\u03b1 expression in human bladder cancer","volume":"73","author":"Tsai","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.03.011_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.urology.2008.11.060","article-title":"Prognostic relevance of prothymosin-\u03b1 expression in human upper urinary tract transitional cell carcinoma","volume":"74","author":"Jou","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.03.011_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.urology.2005.08.034","article-title":"Urine prothymosin-\u03b1 as novel tumor marker for detection and follow-up of bladder cancer","volume":"67","author":"Tzai","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.03.011_bib12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1073\/pnas.81.4.1008","article-title":"Prothymosin \u03b1: Isolation and properties of the major immunoreactive form of thymosin-\u03b1 1 in rat thymus","volume":"81","author":"Haritos","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2012.03.011_bib13","doi-asserted-by":"crossref","first-page":"13286","DOI":"10.1074\/jbc.M213005200","article-title":"Prothymosin \u03b1 is processed to thymosin \u03b1 1 and thymosin \u03b1 11 by a lysosomal asparaginyl endopeptidase","volume":"278","author":"Sarandeses","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2012.03.011_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1196\/annals.1415.002","article-title":"Thymosin \u03b11: An endogenous regulator of inflammation, immunity, and tolerance","volume":"1112","author":"Romani","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.urolonc.2012.03.011_bib15","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1073\/pnas.84.13.4465","article-title":"Prothymosin \u03b1 in human blood","volume":"84","author":"Panneerselvam","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2012.03.011_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0162-3109(88)90054-9","article-title":"Enhancement of human T lymphocyte functions by prothymosin \u03b1","volume":"15","author":"Baxevanis","year":"1988","journal-title":"J Immunopharmacol"},{"key":"10.1016\/j.urolonc.2012.03.011_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1196\/annals.1415.043","article-title":"Influence of prothymosin-\u03b1 on HIV-1 target cells","volume":"1112","author":"Mosoian","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.urolonc.2012.03.011_bib18","first-page":"277","article-title":"Prothymosin \u03b1 enhances human natural killer cell cytotoxicity: Role in mediating signals for NK activity","volume":"11","author":"Cordero","year":"1992","journal-title":"Lympho Cyto Res"},{"key":"10.1016\/j.urolonc.2012.03.011_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1196\/annals.1415.044","article-title":"Thymosin \u03b1 1: From bench to bedside","volume":"1112","author":"Garaci","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.urolonc.2012.03.011_bib20","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1200\/JCO.2003.02.122","article-title":"Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer","volume":"21","author":"Yang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.03.011_bib21","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199804303381805","article-title":"Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma","volume":"338","author":"Negrier","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2012.03.011_bib22","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1200\/JCO.2008.16.9847","article-title":"Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206","volume":"26","author":"Rini","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.03.011_bib23","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2009.26.5561","article-title":"Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: Final results of CALGB 90206","volume":"28","author":"Rini","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.03.011_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1440-1746.2008.05387.x","article-title":"Combination therapy of thymosin \u03b1-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study","volume":"23","author":"Lee","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.urolonc.2012.03.011_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.antiviral.2007.10.014","article-title":"Comparison of the efficacy of thymosin \u03b1-1 and interferon \u03b1 in the treatment of chronic hepatitis B: A meta-analysis","volume":"77","author":"Yang","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.urolonc.2012.03.011_bib26","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0196-9781(02)00025-6","article-title":"Thymosin \u03b11 inhibits mammary carcinogenesis in Fisher rats","volume":"23","author":"Moody","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.urolonc.2012.03.011_bib27","first-page":"5214","article-title":"Thymosin \u03b1 1 down-regulates the growth of human non-small cell lung cancer cells in vitro and in vivo","volume":"53","author":"Moody","year":"1993","journal-title":"Cancer Res"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:04:01Z","timestamp":1761041041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143912000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1078143912000920"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.03.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma thymosin-\u03b11 level as a potential biomarker in urothelial and renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}